ABBV Nov 2024 135.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:50AM EDT. Market open.
Loading interactive chart…
- Insider Monkey
PGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Here’s Why
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund modestly underperformed the S&P 1500 Health Care Index in the quarter which declined 1.1%. Security selection within pharmaceuticals, MedTech, and health care provides & services contributed the most value during the quarter, […]
- Simply Wall St.
Investors in AbbVie (NYSE:ABBV) have seen impressive returns of 235% over the past five years
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...
- Investor's Business Daily
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.
© 2024 Yahoo. All rights reserved.